Could Eli Lilly Be a Trillion-Dollar Company by 2030?
Eli Lilly's valuation has soared over the last year given the blockbuster success of treatments such as Mounjaro and Verzenio. The company has other opportunities, including plaque psoriasis and ps...
El Lilly surpasses Tesla's market size: why has the biotech stock become so attractive?
Barely four years ago, El Lilly (NYSE:LLY) was trading at just around $130. Fast forward, the stock trades at a whopping $627, having recently rubbed a new record price above $645.
Eli Lilly's Wegovy rival Mounjaro gets UK green light
Mounjaro, Eli Lilly's (NYSE:LLY) rival weightloss drug to Wegovy and Ozempic, is to be made available in the UK after receiving the regulatory green light. The UK Medicines and Healthcare products ...
British regulator clears Lilly's injection pen for weight-loss drug Mounjaro
Britain's drug regulator on Thursday said it approved Eli Lilly's injection pen to administer the drug Mounjaro against obesity and diabetes.
Lilly's Mounjaro dose in limited availability in US through next month
A dose of Eli Lilly's diabetes drug Mounjaro has limited availability through February 2024, according to the U.S. Food and Drug Administration's website, due to an increase in demand.
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.
Eli Lilly gene therapy allows child born deaf to hear, clinical trial shows
An Eli Lilly & Co. LLY, -0.47% experimental gene therapy has restored the hearing of a child who was born deaf, the pharmaceutical giant said Tuesday.
Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock
Eli Lilly has a lot of debt, but it's to help expand its manufacturing capacity. It doesn't appear to have much cash, but that's because of investments in R&D.
Cramer taps Eli Lilly as a new member of the 'Magnificent Seven' if Tesla earnings falter
CNBC's Jim Cramer said Tesla may have hit a "growth pause," compared to its Big Tech peers that are still on the rise.
This pharma stock is gearing up for a huge surge
After years of a slowdown in performance and revenue, Eli Lilly (NYSE: LLY) is starting to turn the page. With its innovations in the pharmaceutical sector, most notably in diabetes treatment, its ...
Prediction: This Will Be the First Trillion-Dollar Healthcare Stock
Eli Lilly is the largest healthcare company by market capitalization. The company is unlikely to underperform its similarly-sized peers.
Here's What Investors Should Expect From Eli Lilly Stock in 2024
Eli Lilly just wrapped up a great year for shareholders, and there may be an encore in 2024. The company is going to continue its business development bonanza.
Exclusive: US FDA finds new manufacturing lapses at Eli Lilly plant
U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according to government records obtained by Reuters.
Why Eli Lilly (LLY) Dipped More Than Broader Market Today
Eli Lilly (LLY) reachead $628.91 at the closing of the latest trading day, reflecting a -0.89% change compared to its last close.
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
As investors, our job isn't to predict an unknowable future.
Related Companies